Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1991 Sep;35(9):1900–1904. doi: 10.1128/aac.35.9.1900

Mechanism of action of BAY v 3522, a new cephalosporin with unusually good activity against enterococci.

G Amalfitano 1, A Grossato 1, R Fontana 1
PMCID: PMC245288  PMID: 1952864

Abstract

The in vitro activity of BAY v 3522, a new cephalosporin with unusually good activity against enterococci, was tested on 100 clinical isolates of Enterococcus faecalis. The MIC for 86.3% of the strains was 4 micrograms/ml, whereas the MIC for 13.7% ranged from 8 to 16 micrograms/ml. No differences were found between MICs determined with low- or high-density inocula. The bactericidal activity of BAY v 3522 was tested on eight clinical strains; most strains showed a ca. 3-log decrease of the original inoculum at two to eight times the MIC. The interaction of BAY v 3522 and of other beta-lactams with penicillin-binding proteins (PBPs) was studied with a laboratory strain, E. hirae ATCC 9790, producing a discernible amount of PBP 5, a protein belonging to the family of low-affinity PBPs, responsible for the low susceptibility of enterococci to beta-lactams. PBPs 3 and 5 of ATCC 9790 showed the highest affinity for the new cephalosporin. Bay V 3522 at the MIC (8 micrograms/ml) saturated these two PBPs without any significant binding to the other PBPs. This result may explain the good antienterococcal activity of BAY v 3522.

Full text

PDF
1900

Images in this article

1902Image
on p.1902
1902Image
on p.1902

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bauernfeind A. Comparative in-vitro activity of Sch 34343, imipenem, cefpirome and cefotaxime. J Antimicrob Chemother. 1985 Jun;15 (Suppl 100):155–164. doi: 10.1093/jac/15.suppl_c.155. [DOI] [PubMed] [Google Scholar]
  2. Canepari P., Lleò M. M., Cornaglia G., Fontana R., Satta G. In Streptococcus faecium penicillin-binding protein 5 alone is sufficient for growth at sub-maximal but not at maximal rate. J Gen Microbiol. 1986 Mar;132(3):625–631. doi: 10.1099/00221287-132-3-625. [DOI] [PubMed] [Google Scholar]
  3. Canepari P., Lleò M. M., Fontana R., Satta G. Streptococcus faecium mutants that are temperature sensitive for cell growth and show alterations in penicillin-binding proteins. J Bacteriol. 1987 Jun;169(6):2432–2439. doi: 10.1128/jb.169.6.2432-2439.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Coyette J., Ghuysen J. M., Fontana R. The penicillin-binding proteins in Streptococcus faecalis ATCC 9790. Eur J Biochem. 1980 Sep;110(2):445–456. doi: 10.1111/j.1432-1033.1980.tb04886.x. [DOI] [PubMed] [Google Scholar]
  5. Facklam R. R. Recognition of group D streptococcal species of human origin by biochemical and physiological tests. Appl Microbiol. 1972 Jun;23(6):1131–1139. doi: 10.1128/am.23.6.1131-1139.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fass R. J. In vitro activity of BAY v 3522, a new oral cephalosporin. Antimicrob Agents Chemother. 1990 Sep;34(9):1855–1857. doi: 10.1128/aac.34.9.1855. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fontana R., Boaretti M., Grossato A., Tonin E. A., Lleò M. M., Satta G. Paradoxical response of Enterococcus faecalis to the bactericidal activity of penicillin is associated with reduced activity of one autolysin. Antimicrob Agents Chemother. 1990 Feb;34(2):314–320. doi: 10.1128/aac.34.2.314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fontana R., Canepari P., Lleò M. M., Satta G. Mechanisms of resistance of enterococci to beta-lactam antibiotics. Eur J Clin Microbiol Infect Dis. 1990 Feb;9(2):103–105. doi: 10.1007/BF01963633. [DOI] [PubMed] [Google Scholar]
  9. Fontana R., Canepari P., Satta G., Coyette J. Identification of the lethal target of benzylpenicillin in Streptococcus faecalis by in vivo penicillin binding studies. Nature. 1980 Sep 4;287(5777):70–72. doi: 10.1038/287070a0. [DOI] [PubMed] [Google Scholar]
  10. Fontana R., Cerini R., Longoni P., Grossato A., Canepari P. Identification of a streptococcal penicillin-binding protein that reacts very slowly with penicillin. J Bacteriol. 1983 Sep;155(3):1343–1350. doi: 10.1128/jb.155.3.1343-1350.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fontana R., Grossato A., Ligozzi M., Tonin E. A. In vitro response to bactericidal activity of cell wall-active antibiotics does not support the general opinion that enterococci are naturally tolerant to these antibiotics. Antimicrob Agents Chemother. 1990 Aug;34(8):1518–1522. doi: 10.1128/aac.34.8.1518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fontana R., Grossato A., Rossi L., Cheng Y. R., Satta G. Transition from resistance to hypersusceptibility to beta-lactam antibiotics associated with loss of a low-affinity penicillin-binding protein in a Streptococcus faecium mutant highly resistant to penicillin. Antimicrob Agents Chemother. 1985 Nov;28(5):678–683. doi: 10.1128/aac.28.5.678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fontana R. Penicillin-binding proteins and the intrinsic resistance to beta-lactams in gram-positive cocci. J Antimicrob Chemother. 1985 Oct;16(4):412–416. doi: 10.1093/jac/16.4.412. [DOI] [PubMed] [Google Scholar]
  14. Georgopapadakou N. H., Liu F. Y. Binding of beta-lactam antibiotics to penicillin-binding proteins of Staphylococcus aureus and Streptococcus faecalis: relation to antibacterial activity. Antimicrob Agents Chemother. 1980 Nov;18(5):834–836. doi: 10.1128/aac.18.5.834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hodges T. L., Eliopoulos G. M., Klimm K., Moellering R. C., Jr In vitro activity of BAY v 3522, a new cephalosporin for oral administration. Antimicrob Agents Chemother. 1990 Sep;34(9):1849–1854. doi: 10.1128/aac.34.9.1849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kaye D. Enterococci. Biologic and epidemiologic characteristics and in vitro susceptibility. Arch Intern Med. 1982 Oct 25;142(11):2006–2009. doi: 10.1001/archinte.142.11.2006. [DOI] [PubMed] [Google Scholar]
  17. Krogstad D. J., Pargwette A. R. Defective killing of enterococci: a common property of antimicrobial agents acting on the cell wall. Antimicrob Agents Chemother. 1980 Jun;17(6):965–968. doi: 10.1128/aac.17.6.965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lleó M. M., Canepari P., Cornaglia G., Fontana R., Satta G. Bacteriostatic and bactericidal activities of beta-lactams against Streptococcus (Enterococcus) faecium are associated with saturation of different penicillin-binding proteins. Antimicrob Agents Chemother. 1987 Oct;31(10):1618–1626. doi: 10.1128/aac.31.10.1618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Murray B. E. The life and times of the Enterococcus. Clin Microbiol Rev. 1990 Jan;3(1):46–65. doi: 10.1128/cmr.3.1.46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Toala P., McDonald A., Wilcox C., Finland M. Susceptibility of group D streptococcus (enterococcus) to 21 antibiotics in vitro, with special reference to species differences. Am J Med Sci. 1969 Dec;258(6):416–430. doi: 10.1097/00000441-196912000-00006. [DOI] [PubMed] [Google Scholar]
  21. Williamson R., le Bouguénec C., Gutmann L., Horaud T. One or two low affinity penicillin-binding proteins may be responsible for the range of susceptibility of Enterococcus faecium to benzylpenicillin. J Gen Microbiol. 1985 Aug;131(8):1933–1940. doi: 10.1099/00221287-131-8-1933. [DOI] [PubMed] [Google Scholar]
  22. Wise R., Andrews J. M., Ashby J. P., Thornber D. In vitro activity of Bay v 3522, a new cephalosporin, compared with activities of other agents. Antimicrob Agents Chemother. 1990 May;34(5):813–818. doi: 10.1128/aac.34.5.813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. al-Obeid S., Gutmann L., Williamson R. Correlation of penicillin-induced lysis of Enterococcus faecium with saturation of essential penicillin-binding proteins and release of lipoteichoic acid. Antimicrob Agents Chemother. 1990 Oct;34(10):1901–1907. doi: 10.1128/aac.34.10.1901. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES